CEPH expands Gabitril rights

Cephalon (CEPH) acquired expanded rights outside the U.S. to epilepsy drug Gabitril from Sanofi- Synthelabo (Paris, France) and Novo Nordisk (NVO). Under the deal, CEPH gains rights to Gabitril worldw...